As of 2025-12-13, the Relative Valuation of Ramm Pharma Corp (RAMM.CN) is (0.22) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 CAD, the upside of Ramm Pharma Corp based on Relative Valuation is -649.7%.
The range of the Relative Valuation is (0.15) - (0.25) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.0x - 4.8x | 3.4x |
| Forward P/E multiples | 1.7x - 3.4x | 2.6x |
| Fair Price | (0.15) - (0.25) | (0.22) |
| Upside | -473.2% - -731.9% | -649.7% |
| Date | P/E |
| 2025-12-01 | -0.81 |
| 2025-11-28 | -0.74 |
| 2025-11-27 | -0.74 |
| 2025-11-21 | -1.01 |
| 2025-11-17 | -0.74 |
| 2025-11-13 | -1.22 |
| 2025-11-11 | -1.01 |
| 2025-11-10 | -1.08 |
| 2025-11-07 | -1.35 |
| 2025-10-30 | -0.20 |
| 2025-10-29 | -0.27 |
| 2025-10-28 | -0.27 |
| 2025-10-24 | -0.14 |
| 2025-10-07 | -0.20 |
| 2025-09-26 | -0.14 |
| 2025-09-23 | -0.20 |
| 2025-09-19 | -0.20 |
| 2025-09-18 | -0.14 |
| 2025-09-17 | -0.14 |
| 2025-09-12 | -0.14 |